STOCK TITAN

Processa Pharmaceuticals, Inc. (PCSA) grants 9,450 RSUs to its CAO

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Processa Pharmaceuticals, Inc. reported that Chief Administrative Officer Wendy Guy received a grant of 9,450 Restricted Stock Units on 2026-07-26, each representing one share of common stock. These RSUs vested on grant but will be delivered in shares at the earlier of termination, six months after grant, a change of control, or death.

After this award, Guy holds 11,669 RSUs directly, stock options for 6,000 shares at an exercise price of $4.9600 vesting over three years, 14,394 shares of common stock directly, and 333 shares indirectly through CorLyst, LLC.

Positive

  • None.

Negative

  • None.
Insider Guy Wendy
Role Chief Administrative Officer
Type Security Shares Price Value
Grant/Award Restricted Stock Units F1, F3 9,450 $0.00 $0.00
holding Stock Options (Right to Buy) F2, F3 -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Restricted Stock Units — 11,669 shares (Direct); Stock Options (Right to Buy) — 6,000 shares (Direct); Common Stock — 14,394 shares (Direct); Common Stock — 333 shares (Indirect, By CorLyst, LLC)
Footnotes (3)
  1. F1. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death.
  2. F2. Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.
  3. F3. Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025.
Restricted Stock Units granted 9,450 units RSU grant to Wendy Guy on 2026-07-26
RSUs held after grant 11,669 units Total Restricted Stock Units held directly after reported award
Stock option exercise price $4.9600 per share Exercise price for stock options over common stock held directly
Underlying option shares 6,000 shares Common shares underlying stock options held directly
Direct common shares 14,394 shares Direct common stock ownership by Wendy Guy after reported transactions
Indirect common shares 333 shares Common stock held indirectly through CorLyst, LLC
Reverse stock split ratio 1-for-25 Reverse stock split effected on December 17, 2025
Restricted Stock Units financial
"Each Restricted Stock Unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Options (Right to Buy) financial
"Stock Options (Right to Buy) with an exercise price of 4.9600"
reverse stock split financial
"Reflects the 1-for-25 reverse stock split effected by the Issuer"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
vesting financial
"Stock options vest one-third on the first anniversary date of the grant"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What equity award did Processa Pharmaceuticals (PCSA) grant to Wendy Guy?

Processa Pharmaceuticals granted Chief Administrative Officer Wendy Guy 9,450 Restricted Stock Units on 2026-07-26, each convertible into one share of common stock. The units vested immediately but will be settled in shares at the earlier of termination, six months after grant, a change of control, or death.

How many Processa Pharmaceuticals (PCSA) RSUs does Wendy Guy hold after this grant?

Following the grant, Wendy Guy directly holds 11,669 Restricted Stock Units of Processa Pharmaceuticals. Each RSU represents a contingent right to receive one share of common stock, subject to distribution timing based on termination, six months after grant, change of control, or death.

What Processa Pharmaceuticals (PCSA) stock options does Wendy Guy hold?

Wendy Guy holds stock options over 6,000 shares of Processa common stock with an exercise price of $4.9600 per share. These options vest one-third on the first anniversary of the grant, with the remaining options vesting ratably over the subsequent two years.

What are Wendy Guy’s direct and indirect common share holdings in Processa (PCSA)?

After the reported transactions, Wendy Guy owns 14,394 common shares of Processa Pharmaceuticals directly and an additional 333 common shares indirectly through CorLyst, LLC. These positions are separate from her Restricted Stock Units and stock options reported in the same filing.

How does the 1-for-25 reverse stock split affect Wendy Guy’s Processa (PCSA) holdings?

Reported post-transaction amounts, including 11,669 RSUs and option-related figures, reflect a 1-for-25 reverse stock split effective December 17, 2025. This split adjusted share and unit counts proportionally but did not itself represent a new transaction by Wendy Guy.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Guy Wendy

(Last)(First)(Middle)
C/O PROCESSA PHARMACEUTICALS, INC.
601 21ST STREET SUITE 300

(Street)
VERO BEACH FLORIDA 32960

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Processa Pharmaceuticals, Inc. [ PCSA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Administrative Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/26/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock14,394D
Common Stock333IBy CorLyst, LLC
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units$007/26/2026A9,450(1) (1) (1)Common Stock9,450$011,669(3)D
Stock Options (Right to Buy)$4.96 (2) (2)Common Stock6,0006,000(3)D
Explanation of Responses:
1. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. These RSUs vested upon grant, but will not be distributed until the earlier of: (i) their termination; (ii) six month anniversary of the grant date; (iii) change of control; or (iv) their death.
2. Stock options vest one-third on the first anniversary date of the grant, with the remaining options vesting ratably over the subsequent two years.
3. Reflects the 1-for-25 reverse stock split effected by the Issuer on December 17, 2025.
/s/ Wendy Guy by John J. Wolfel, as Attorney-in-Fact07/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)